If President Joe Biden and the Democratic Party were counting on another ruling from the Supreme Court forcing abortion back into the mainstream of political issues, they should be bracing for disappointment.
On Tuesday, the court heard oral arguments in a case that seeks to roll back the Food and Drug Administration’s approval of the drug mifepristone, a commonly prescribed abortion pill. The issue before the court was twofold: whether the plaintiffs had standing, and if they did, whether the FDA violated the Administrative Procedures Act when it changed the rules for prescription of the drug in 2016 and 2021.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.